Share this article Share this article LOS ANGELES, Jan. 12, 2021 /PRNewswire/ -- Monarch Biosciences, Inc. (MonarchBio), a California-based life sciences company, announced today that it has recently received Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for the following U.S. patent applications: No. 16/298,758 entitled "Three-Dimensional Thin-Film Nitinol Devices" (U.S. Patent 10,864,096) No. 16/010,341 entitled "Intrasaccular Thin-film Flow Diverters and Related Methods" No. 15/605,754 entitled "Thin-Film Cuff for Endothelialization of Endovascular Grafts" No. 16/048,136 entitled "Thin-Film Micromesh and Related Methods" Haynes and Boone LLP represented MonarchBio in the successful prosecution of these patent applications and other related applications. The claims of the patent applications cover the manufacturing of three-dimensional thin-film nitinol (TFN) constructs and include TFN-based intrasaccular flow diverters, cuffs for endovascular grafts and thin-film micromesh devices, which may be fabricated via sputter deposition on a micropatterned silicon wafer. Nitinol is a super-elastic nickel and titanium alloy with unique properties that allow deformation and subsequent full recovery of the original shape upon exposure to body heat.